Want to see AU:CSX full AI Analyst Report?
CSX Stock Chart & Stats
AU$0.42
AU$0.01(2.53%)
At close: 4:00 PM EDT
AU$0.42
AU$0.01(2.53%)
Day’s Range― - ―
52-Week RangeAU$0.32 - AU$0.82
Previous CloseN/A
Volume347.85K
Average Volume (3M)60.70K
Market Cap
AU$37.70M
Enterprise ValueAU$23.11
Total Cash (Recent Filing)AU$10.08M
Total Debt (Recent Filing)AU$1.45M
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Feb 25, 2027EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding79,364,860
10 Day Avg. Volume64,350
30 Day Avg. Volume60,696
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)1.70
Price to Sales (P/S)1.59
P/FCF Ratio-221.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)AU$24.40M
Bulls Say, Bears Say
Bulls Say
Low LeverageLow leverage and a sizeable equity base provide financial flexibility to fund product development, sales expansion and working-capital needs. This reduces balance-sheet pressure while management works toward sustainable profitability.
Recurring Consumables ModelThe installed base can generate recurring demand beyond initial respirator sales through filters, masks, accessories and replacement parts. This creates an opportunity for more durable customer relationships and revenue visibility as adoption expands.
Improved Operating Cash FlowThe shift from very weak operating cash flow in 2022–2024 to positive levels in 2025–2026 indicates some progress in cash conversion. Although still modest, sustained improvement could reduce reliance on external funding over time.
Bears Say
Persistent LossesOngoing losses show that the current revenue base and cost structure have not yet produced a self-sustaining business. Continued negative margins can consume equity and constrain investment unless scale, pricing or operating efficiency improves.
Volatile Revenue And MarginsUneven revenue growth and a sharp 2026 gross-margin decline suggest product economics remain sensitive to demand, mix or pricing. This volatility makes forecasting difficult and delays the company’s ability to convert market adoption into durable profits.
Renewed Free Cash Flow BurnThe return to negative free cash flow indicates that operations and investment are not yet consistently self-funded. If the pattern persists, CleanSpace may need to draw on its balance sheet or raise capital, increasing execution and funding risk.
CleanSpace Holdings Ltd. News
CSX FAQ
What was CleanSpace Holdings Ltd.’s price range in the past 12 months?
CleanSpace Holdings Ltd. lowest share price was AU$0.32 and its highest was AU$0.82 in the past 12 months.
What is CleanSpace Holdings Ltd.’s market cap?
CleanSpace Holdings Ltd.’s market cap is AU$37.70M.
When is CleanSpace Holdings Ltd.’s upcoming earnings report date?
CleanSpace Holdings Ltd.’s upcoming earnings report date is Feb 25, 2027 which is in 171 days.
How were CleanSpace Holdings Ltd.’s earnings last quarter?
CleanSpace Holdings Ltd. released its earnings results on Aug 27, 2026. The company reported -AU$0.033 earnings per share for the quarter, missing the consensus estimate of -AU$0.001 by -AU$0.032.
Is CleanSpace Holdings Ltd. overvalued?
According to Wall Street analysts CleanSpace Holdings Ltd.’s price is currently Overvalued.
Does CleanSpace Holdings Ltd. pay dividends?
CleanSpace Holdings Ltd. does not currently pay dividends.
What is CleanSpace Holdings Ltd.’s EPS estimate?
CleanSpace Holdings Ltd.’s EPS estimate is <0.01.
How many shares outstanding does CleanSpace Holdings Ltd. have?
CleanSpace Holdings Ltd. has 79,364,860 shares outstanding.
What happened to CleanSpace Holdings Ltd.’s price movement after its last earnings report?
CleanSpace Holdings Ltd. reported an EPS of -AU$0.033 in its last earnings report, missing expectations of -AU$0.001. Following the earnings report the stock price went up 3.75%.
Which hedge fund is a major shareholder of CleanSpace Holdings Ltd.?
Currently, no hedge funds are holding shares in AU:CSX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CleanSpace Holdings Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.31%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-14.92%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CleanSpace Holdings Ltd.
CleanSpace Holdings Limited is a global enterprise focused on the design, manufacturing, and sale of personal respiratory protective equipment and related services. The company's advanced solutions serve healthcare professionals and a wide array of industrial employers worldwide. Their key offerings include CleanSpace HALO, specifically designed for medical and healthcare environments; CleanSpace ULTRA, providing robust face, eye, and water-resistant protection; CleanSpace2, a versatile respirator for general industrial settings; and CleanSpace EX, engineered for safe operation in potentially explosive atmospheres. Furthermore, CleanSpace supplies an extensive range of accessories and consumable products, such as various masks, replacement filters, charging and storage solutions, specialized biohoods, adaptors, identification elements, headgear components, protective visors, and essential spare parts. This protective gear is deployed across diverse and demanding sectors, including mining, welding, construction, laboratories, dental practices, wastewater management, and critical healthcare and first responder roles. Founded in 2009, CleanSpace Holdings Limited maintains its headquarters in St Leonards, Australia.
Technical Analysis
Compumedics Limited
―
Atomo Diagnostics Ltd.
―
Cyclopharm Limited
―
Micro-X Ltd.
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―